Rabeprazole and Muscle function loss - a phase IV clinical study of FDA data

Summary:

Muscle function loss is reported as a side effect among people who take Rabeprazole (rabeprazole sodium), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Ativan, and have Pain.

The phase IV clinical study analyzes which people have Muscle function loss when taking Rabeprazole. It is created by eHealthMe based on reports of 31,196 people who have side effects when taking Rabeprazole from the FDA, and is updated regularly.

What is Rabeprazole?

Rabeprazole has active ingredients of rabeprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 31,689 Rabeprazole users. Check the latest studies of Rabeprazole.

What is Muscle function loss?

Muscle function loss is found to be associated with 1,001 drugs and 1,521 conditions by eHealthMe. Check the latest studies of Muscle function loss.

On Jul, 08, 2026

31,196 people reported to have side effects when taking Rabeprazole.
Among them, 46 people (0.15%) have Muscle function loss.

Could Rabeprazole cause Muscle function loss?

Among these 46 people:

How long have people been on Rabeprazole when they have Muscle function loss? *

What is the gender of people who have Muscle function loss when taking Rabeprazole? *

female: 67.5 %
male: 32.5 %

What is the age of people who have Muscle function loss when taking Rabeprazole? *

What are other drugs people take besides Rabeprazole? *

What are other side effects people have besides Muscle function loss? *

Weakness: 19 people, 41.30%
Fall: 18 people, 39.13%
Gait Disturbance: 17 people, 36.96%
Diarrhea: 16 people, 34.78%
Fever: 14 people, 30.43%
Hypoaesthesia (reduced sense of touch or sensation): 13 people, 28.26%
Swallowing Difficulty: 13 people, 28.26%
Fatigue (feeling of tiredness): 12 people, 26.09%
Nausea And Vomiting: 12 people, 26.09%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 11 people, 23.91%

What are the existing conditions these people have? *

Pain: 14 people, 30.43%
Stress And Anxiety: 12 people, 26.09%
Insomnia (sleeplessness): 11 people, 23.91%
High Blood Pressure: 10 people, 21.74%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 9 people, 19.57%
Metastases To Bone (cancer spreads to bone): 9 people, 19.57%
Multiple Myeloma (cancer of the plasma cells): 9 people, 19.57%
Hiccups (an involuntary spasm of the diaphragm and respiratory organs, with a sudden closure of the glottis and a sound like a cough): 9 people, 19.57%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 7 people, 15.22%
Constipation: 6 people, 13.04%

* Approximation only. Some reports may have incomplete information.

Do you take Rabeprazole and have Muscle function loss?

- Check whether Muscle function loss is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rabeprazole:

Rabeprazole (31,689 reports)

Browse all side effects of Rabeprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Muscle function loss:

Muscle function loss (1,001 drugs)

Browse all the conditions that are associated with Muscle function loss:

Muscle function loss (1,521 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rabeprazole sodium (the active ingredients of Rabeprazole) and Rabeprazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.